Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Sensors (Basel, Switzerland)|July 28, 2022
A Novel Design and Development of a Strip-Fed Circularly Polarized Rectangular Dielectric Resonator Antenna for 5G NR Sub-6 GHz Band ApplicationsUsman Illahi, Javed Iqbal, Muhammad Irfan, et al.Leukemia & Lymphoma|November 23, 2022
Central nervous system involvement by mantle cell lymphomaNicole McLaughlin, Yucai Wang, Thomas Witzig, et al.JCO Oncology Practice|May 13, 2020
Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology SurveyDavid M Waterhouse, R Donald Harvey, Patricia Hurley, et al.Clinical Lymphoma, Myeloma & Leukemia|October 1, 2015
Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center ExperienceMoussab Damlaj, Nanna H Sulai, Jennifer L Oliveira, et al.Leukemia & Lymphoma|February 20, 2014
Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphomaLuis F Porrata, Kay M Ristow, Thomas M Habermann, et al.Leukemia & Lymphoma|July 11, 2022
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial designKristine Broglio, Lale Kostakoglu, Carol Ward, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical EfficacyJennifer R Diamond, Valentina Boni, Emerson Lim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell LymphomaNancy L Bartlett, Uwe Hahn, Won-Seog Kim, et al.American Journal of Hematology|March 4, 2021
Relapsed/Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphomaMatthew J Maurer, Lasse H Jakobsen, Raphael Mwangi, et al.Hematological Oncology|November 29, 2024
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment ResistanceAllison M Bock, Kerstin Wenzl, Joseph P Novak, et al.Pageof 3